MEDLINE INC-CL A
MDLNNASDAQTrading Snapshot
- Day Range
- $34.83 β $35.39
- 52-Week Range
- $31.49 β $50.88
- Volume
- $3.46B
- Avg Volume
- $4.11B
- Shares Outstanding
- 845.6M
- Next Earnings
- Dec 14, 2026
Fundamentals Snapshot
- Annual Revenue
- $28.43B
- Last Q Revenue
- $7.68B
- P/E Ratio
- 40.6
- P/S Ratio
- 1.0x
- EPS (TTM)
- $0.81
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.2%
Why Investors Own MDLN
- βHigh-growth profile β revenue up +17.8% YoY with expanding US Equity exposure.
- βHealthy economics β 79% gross margin and 23% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MEDLINE INC-CL A
MDLNAbout MEDLINE INC-CL A
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities Fraud Investigation
BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Sept.

MEDLINE INC. INVESTIGATION: MDLN Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Medline Inc. (βMedlineβ or the βCompanyβ) (NASDAQ: MDLN). The investigation concerns whether the

Kaplan Fox is Investigating Medline Inc. (MDLN) on Behalf of Shareholders for Possible Securities Law Violations
New York, New York--(Newsfile Corp. - September 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO REC

MDLN Investor Investigation: Medline Under Investigation for Securities Fraud on behalf of Investors with Losses β Contact BFA Law
BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Sept.

MDLN Stock Drop Alert: Medline Stock Plummets 13% after Product Quality Issues Revealed β BFA Law Notifies Investors of its Ongoing Securities Fraud Investigation
NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firmΒ Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock d

Kaplan Fox Advises Investors of Medline Inc. (MDLN) to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO REC